Delivery Order SPE2DR25D1047-SPE2DR26F24B6
- Not listed
- The Defense Logistics Agency awarded a $1,474.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packages of 5 grams. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of November 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (50 mg/5 g) in unit-dose 5-gram packages, with a ceiling value of $1,408.87. The contract is a firm fixed-price delivery order with an ultimate completion date of December 2, 2025, awarded on December 1, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and represents a...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,032.07 to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (50 mg/5 g) in unit dose 5-gram packets. This is a firm fixed price contract with an ultimate completion date of June 9, 2025, and represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,518.22 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a non-set-aside competitive award with an ultimate completion date of May 13, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams, with a ceiling value of $1,235.12. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,160.00 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a completion date of December 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, serving as the place of performance. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $3,599.50 delivery order to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of September 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. As a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a $1,344.52 delivery order to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This firm fixed-price delivery order, issued on August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,428.90 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,605.63 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5 gram packages on August 22, 2025, with completion expected by August 25, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken,...
- SPE2DR25D1047Indefinite Delivery Contract
- SPE2DR25D1047-SPE2DR26F24B6Delivery Order
The Defense Logistics Agency awarded a $1,073.05 delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (50 mg/5 g) in unit dose packaging of 5 grams, with an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order supports the pharmaceutical supply needs of military and federal healthcare systems through DLA's comprehensive medical supply chain. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and critical federal medical vendor, regularly fulfills orders for brand-name and generic medications, hormone treatments, and specialized medical supplies across multiple therapeutic domains. The firm fixed-price structure and absence of set-aside designation reflect the company's demonstrated capability to meet federal procurement requirements through open competition, consistent with its extensive portfolio of previous federal medical supply contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/17/25 |